Endosonographic staging of lower intestinal malignancy

Area of Science:

• Gastroenterology
• Medical Imaging
• Oncology

Background:

• Endoscopic ultrasound (EUS) is established for rectal pathology assessment.
• Accurate staging of lower intestinal tumors is crucial for prognosis and treatment planning.
• EUS offers significant benefits in evaluating rectal, colonic, and anal pathologies.

Purpose of the Study:

• To evaluate the established role and accuracy of EUS in staging rectal tumors.
• To explore the evolving application and effectiveness of EUS in colonic and anal pathology staging.
• To highlight the impact of technological advancements on EUS accuracy.

Main Methods:

• Review of current literature on EUS for lower intestinal, colonic, and anal pathology.
• Analysis of reported accuracy rates for T and N staging using EUS in rectal cancer.
• Assessment of advancements in EUS technology, such as high-resolution 3D and miniprobe EUS.

Main Results:

• EUS is considered the gold standard for rectal tumor staging, with T stage accuracy of 75-95% and N stage accuracy of 65-80%.
• Advances in high-resolution 3D EUS have significantly improved rectal staging accuracy.
• Miniprobe EUS has enhanced the assessment of colonic tumors, though its role is less established than for rectal cancer.
• EUS is beneficial for anal pathology, but histological correlation requires further establishment.

Conclusions:

• EUS is a highly accurate and established method for staging rectal tumors, guiding patient treatment.
• EUS technology advancements are improving its utility in colonic and anal pathology assessment.
• Further research is needed to solidify the role of EUS in anal pathology staging and histological correlation.